It’s one of America’s biggest killers. Cancer, second to heart disease, took more than 600,000 American lives in 2022. With nearly 2 million new cases diagnosed annually, tens of thousands of patients suffering from cancer opt for various therapies, including chemotherapy.
Chemo – long known for unpleasant side effects — and other invasive surgical treatments have inspired one biotech leader to the ongoing success of precision medicines. Biotech advances in next-generation sequencing and molecular profiling are helping uncover and design treatments for the genetic culprits of disease.
Improving safety and efficacy with a more targeted approach to therapy — Endeavor Biomedicines is dedicated to helping patients feel better and live longer.